We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
COVID‐19 and biologic therapies in dermatology: seroprevalence survey and severity analysis in a tertiary hospital in Spain.
- Authors
Barrutia, Leire; Volo, Victor; Ruíz‐Sánchez, Daniel; Valtueña, Jara; Aguado García, Angel; Manchado López, Pilar
- Abstract
We then excluded patients that did not want to participate in the study and those who had stopped treatment during the pandemic, finally obtaining 99 patients ( I n i = 99). Dear Editor, Herein, we report our real-life experience with dermatologic patients treated with biologic therapies during the months of peak incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in a tertiary hospital in Valladolid, a medium-sized city in central Spain. We conducted a SARS-CoV-2 seroprevalence survey, and we analyzed the severity of SARS-CoV-2 infections among patients treated with biologic therapies.
- Subjects
SPAIN; COVID-19 treatment; COVID-19; PSORIATIC arthritis; SEROPREVALENCE; URTICARIA
- Publication
International Journal of Dermatology, 2021, Vol 60, Issue 5, p624
- ISSN
0011-9059
- Publication type
Article
- DOI
10.1111/ijd.15467